Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of WHO-approved TRC-ID Regimen with a Chromatographically Purified Vero Cell Rabies Vaccine in Children
TCTR20171016001Phase 4Completed
- Sponsor
- Liaoning Chengda Biotechnology Co., Ltd.
- Start
- Jan 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of Purified Vero cell rabies vaccine in rabies, sponsored by Liaoning Chengda Biotechnology Co., Ltd.. Started Jan 2015; status: completed.
02
Drugs
Purified Vero cell rabies vaccine
03
Conditions
rabies
Beyond the preview
Go deeper on TCTR20171016001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20171016001.